{"certainAgreement":{"otherDetails":"After (a) sponsor publication of the comprehensive multi-center clinical trial results; (b) sponsor notification that the multi-center clinical trial submission is no longer planned; or (c) the 18-month anniversary of the completion or early termination of the multi-center clinical trial, the PI (institution/investigator) may publish or publicly present the study data in accordance with the provisions set forth by the sponsor.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"Compared to investigator-assessed response with its challenging interpretations of any differences in ORR by central adjudication, ORR by centrally adjudicated mIWG-MRT-ECNM criteria as assessed by the study steering committee is the most accurate and reliable evaluation of response to treatment in AdvSM."},"pointOfContact":{"email":"medinfo@blueprintmedicines.com","organization":"Blueprint Medicines","phone":"1-888-258-7768","title":"Blueprint Medicines Medical Information"}}